COMMUNIQUÉS West-GlobeNewswire

New CEO Leads Terumo BCT’s Ambition to Shape the Future of Blood and Cell Technologies in Healthcare
01/04/2019
Antoinette Gawin Focuses on Terumo BCT’s Potential to Treat Disease and Play a Greater Role in Cell Therapy and Regenerative Medicine—Serving More Patients LAKEWOOD, Colo., April 01, 2019 (GLOBE NEWSWIRE) -- Antoinette [...]
MannKind Receives $12.5 Million Milestone Payment from United Therapeutics
01/04/2019
WESTLAKE VILLAGE, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that it achieved the first of several specified development milestones under its licensing and [...]
Announcement About Convening of the Extraordinary General Meeting of Shareholders of Joint Stock Company “Olainfarm”
01/04/2019
Management Board of the Joint Stock Company Olainfarm (JSC Olainfarm), unitary registration number. 40003007246, registered address: Rupnicu iela 5, Olaine, LV-2114, announces that on April 1st, 2019, request to convene [...]
TLC Reports Fourth Quarter and Full Year 2018 Financial Results and Business Update
01/04/2019
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, April 01, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of [...]
Wildflower est mentionné dans une publication de NetworkNewsWire consacrée aux possibilités associées à la popularité grandissante du CBD
01/04/2019
NEW YORK, 01 avr. 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) a annoncé aujourd’hui être mentionnée dans un éditorial publié par NetworkNewsWire (« NNW »), une entreprise [...]
Enzymatica AB: - Publication of the annual report 2018
01/04/2019
Press release 1 April, 2019 Enzymatica - publication of the annual report 2018 Enzymatica announces today that the annual report 2018 is available on the company's web site www.enzymatica.se . The annual report is [...]
Press release: Terveystalo continues to grow its footprint in well-being services: Kajaanin OMT-Fysioterapia Oy to become part of Terveystalo
01/04/2019
Terveystalo is acquiring Kajaanin OMT-Fysioterapia Oy as at 29 March 2019. The company’s employees will be transferred to Terveystalo as old employees and the operations will continue on the same premises as before in [...]
Neovacs announces an agreement with Biosyn GmbH to diversify its supply of Keyhole Limpet Hemocyanin (KLH)
01/04/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES AN AGREEMENT WITH BIOSYN GmbH TO DIVERSIFY ITS SUPPLY OF KEYHOLE LIMPET HEMOCYANIN (KLH ) Paris et Boston, april 1 st 2019 - 07h30 CEST - Neovacs (Euronext [...]
Néovacs annonce un accord avec Biosyn GmbH afin de diversifier son approvisionnement en Keyhole Limpet Hemocyanin (KLH)
01/04/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE N É OVACS ANNONCE UN ACCORD AVEC BIOSYN GmbH AFIN DE DIVERSIFIER SON APPROVISIONNEMENT EN KEYHOLE LIMPET HEMOCYANIN (KLH) Paris et Boston, le 1 er avril [...]
Novartis adds clinical and preclinical anti-inflammatory programs to portfolio with acquisition of IFM Tre
01/04/2019
Acquisition will give Novartis one clinical and two preclinical programs targeting the NLRP3 inflammasome, a key component of the innate immune system Selective inhibition of the NLRP3 inflammasome is a potentially [...]
ObsEva SA to Participate in Upcoming Investor Conferences
01/04/2019
Geneva, Switzerland and Boston, MA – April 1, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Innate Pharma highlights next generation of cancer immunotherapies at the American Association of Cancer Research (AACR) 2019 annual meeting
01/04/2019
INNATE PHARMA HIGHLIGHTS NEXT GENERATION OF CANCER IMMUNOTHERAPIES AT THE AMERICAN ASSOCIATION OF CANCER RESEARCH (AACR) 2019 ANNUAL MEETING New preclinical data highlights IPH5201 (anti-CD39) and IHP5301 (anti-CD73) [...]
Innate Pharma à l’AACR 2019 : nouvelles données sur la prochaine génération d’immunothérapies des cancers
01/04/2019
INNATE PHARMA A L’AACR 2019 : NOUVELLES DONNÉES SUR LA PROCHAINE GÉNÉRATION D’IMMUNOTHÉRAPIES DES CANCERS Nouvelles données précliniques sur IPH5201 (anti-CD39) et IPH5301 (anti-CD73) ciblant la voie adénosine Premières [...]
Publication of the annual report and invitation to the annual shareholders' meeting
31/03/2019
Nomination of Mr. Peter Guenter for Galapagos' board of directors Mechelen, Belgium; 29 March 2019, 22.15 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) published its annual report for the [...]
Neon Therapeutics Presents Updated Data from Ongoing Phase 1b NT-001 Clinical Trial of Personal Neoantigen Vaccine NEO-PV-01 at AACR 2019 Annual Meeting
31/03/2019
Post-Vaccine Immune and Pathologic Markers Associated with Durable Clinical Benefit in Metastatic Melanoma Patient Cohort Top-line Results, Including 52-Week Clinical Outcomes, from Full NT-001 Trial in Melanoma, Non- [...]
Imvax Announces Positive Results from Clinical Trial of Novel IGV-001 Autologous Cell Vaccine in Treating Patients with Newly Diagnosed Glioblastoma
31/03/2019
Median overall survival was 21.9 months for highest vaccine dose vs. 14.6 months i n published standard of care studies Median progression-free survival was 10.4 months vs. 6.9 and 5.4 months in published standard of [...]
Atara Biotherapeutics Announces Collaborator Presentation of Positive Phase 1 Clinical Results for a Mesothelin-Targeted CAR T Immunotherapy in Patients with Advanced Mesothelioma
31/03/2019
Memorial Sloan Kettering Cancer Center collaborators presented results that a regionally delivered mesothelin-targeted, autologous CAR T was well-tolerated and showed encouraging anti-tumor activity in combination with [...]
Novelion Therapeutics Observes World Lipodystrophy Day
31/03/2019
VANCOUVER, British Columbia and CAMBRIDGE, Mass., March 31, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals [...]
Bio-on board of directors approves Draft Budget and IAS/IFRS Consolidated Financial Statement at 31 December 2018
30/03/2019
Consolidated revenues of 51 million Euro at 31 December 2018 compared to 11 million Euro at 31 December 2017; EBITDA of 42 million Euro at 31 December 2018 compared to 7 million Euro at 31 December 2017; EBIT of 40 [...]

Pages